应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
INSM Insmed
休市中 04-26 16:00:00 EDT
24.80
-0.12
-0.48%
盘后
24.80
+0.00
0.00%
19:55 EDT
最高
25.06
最低
24.63
成交量
129.41万
今开
24.92
昨收
24.92
日振幅
1.71%
总市值
36.84亿
流通市值
36.49亿
总股本
1.49亿
成交额
3,213万
换手率
0.88%
流通股本
1.47亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Insmed Incorporated盘中异动 早盘大幅拉升5.10%报25.34美元
自选股智能写手 · 04-23
Insmed Incorporated盘中异动 早盘大幅拉升5.10%报25.34美元
Insmed(INSM.US)获Truist Securities首次覆盖,给予买入评级, 目标价48.00美元。
智通财经 · 04-23
Insmed(INSM.US)获Truist Securities首次覆盖,给予买入评级, 目标价48.00美元。
Insmed Inc盘中异动 股价大跌5.07%报26.39美元
自选股智能写手 · 02-13
Insmed Inc盘中异动 股价大跌5.07%报26.39美元
小摩:予Insmed(INSM.US)等六只大型生物科技股“增持”评级
智通财经网 · 2023-11-27
小摩:予Insmed(INSM.US)等六只大型生物科技股“增持”评级
暂无数据
公司概况
公司名称:
Insmed
所属市场:
NASDAQ
上市日期:
--
主营业务:
Insmed Incorporated是一家生物制药公司,专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法,证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果,安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。
发行价格:
--
{"stockData":{"symbol":"INSM","market":"US","secType":"STK","nameCN":"Insmed","latestPrice":24.8,"timestamp":1714161600000,"preClose":24.92,"halted":0,"volume":1294138,"hourTrading":{"tag":"盘后","latestPrice":24.8,"preClose":24.8,"latestTime":"19:55 EDT","volume":85996,"amount":2132675.74,"timestamp":1714175756681},"delay":0,"floatShares":147152647,"shares":148555217,"eps":-5.34,"marketStatus":"休市中","marketStatusCode":7,"change":-0.12,"latestTime":"04-26 16:00:00 EDT","open":24.92,"high":25.055,"low":24.63,"amount":32126729.96378,"amplitude":0.017055,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.34,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"listingDate":959832000000,"adjPreClose":24.92,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":24.8,"preClose":24.8,"latestTime":"19:55 EDT","volume":85996,"amount":2132675.74,"timestamp":1714175756681},"volumeRatio":0.43428909919713843},"requestUrl":"/m/hq/s/INSM/tweets","defaultTab":"tweets","newsList":[{"id":"2429511342","title":"Insmed Incorporated盘中异动 早盘大幅拉升5.10%报25.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429511342","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429511342?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:48","pubTimestamp":1713880112,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时48分,Insmed Incorporated股票出现异动,股价大幅上涨5.10%。Insmed Incorporated股票所在的生物技术行业中,整体涨幅为1.16%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。消息层面,截至21时48分,《Insmed获Truist Securities首次覆盖,给予买入评级, 目标价48.00美元。》资讯为影响Insmed Incorporated的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232148337a54ee2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232148337a54ee2d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429198582","title":"Insmed(INSM.US)获Truist Securities首次覆盖,给予买入评级, 目标价48.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429198582","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429198582?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:46","pubTimestamp":1713869173,"startTime":"0","endTime":"0","summary":"Insmed(INSM.US)获Truist Securities首次覆盖,给予买入评级, 目标价48.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042318461687a5d2a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042318461687a5d2a5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411368050","title":"Insmed Inc盘中异动 股价大跌5.07%报26.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411368050","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411368050?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:35","pubTimestamp":1707834930,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时35分,Insmed Inc股票出现异动,股价急速下跌5.07%。Insmed Inc股票所在的生物技术行业中,整体跌幅为0.71%。其相关个股中,Biodexa Pharmaceuticals Plc、Bioxcel Therapeutics Inc、联拓生物涨幅较大,Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃,换手率分别为301.99%、86.33%、36.14%,振幅较大的相关个股有Adial Pharmaceuticals Inc、Kalvista Pharmaceuticals Inc、Biodexa Pharmaceuticals Plc,振幅分别为15.91%、15.02%、12.41%。Insmed Inc公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322353079113bee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322353079113bee&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2386797831","title":"小摩:予Insmed(INSM.US)等六只大型生物科技股“增持”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2386797831","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2386797831?lang=zh_cn&edition=full","pubTime":"2023-11-27 08:16","pubTimestamp":1701044183,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,摩根大通在最近的一份报告中恢复了对15只大型生物科技股的评级。具体来看,该行予Insmed、Denali、Immunocore、Crinetics、Mirum和BioCryst“增持”评级,予Cervel Therapeutics 、Alkermes、Novocure、Deciphera、Stoke和Esperion“中性”评级,予Amarin、Emergent BioSolutions和Nektar Therapeutics“减持”评级。对于Insmed,小摩认为,在近期研究更新的背景下、以及其对brensocatib治疗非囊性纤维化支气管扩张的ASPEN研究的“备受期待”的数据公布之前,该股预计将走高。在肿瘤药物Kimmtrak强势上市后,小摩同样看好Immunocore股票的上行空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1029339.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.insmed.com","stockEarnings":[{"period":"1week","weight":0.0197},{"period":"1month","weight":-0.0922},{"period":"3month","weight":-0.105},{"period":"6month","weight":0.0385},{"period":"1year","weight":0.2883},{"period":"ytd","weight":-0.1997}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insmed Incorporated是一家生物制药公司,专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法,证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果,安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.07032},{"month":2,"riseRate":0.393939,"avgChangeRate":0.079495},{"month":3,"riseRate":0.382353,"avgChangeRate":-0.053522},{"month":4,"riseRate":0.411765,"avgChangeRate":0.050813},{"month":5,"riseRate":0.393939,"avgChangeRate":0.035437},{"month":6,"riseRate":0.515152,"avgChangeRate":0.008782},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.00007},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.03265},{"month":9,"riseRate":0.575758,"avgChangeRate":0.033632},{"month":10,"riseRate":0.424242,"avgChangeRate":-0.023724},{"month":11,"riseRate":0.636364,"avgChangeRate":0.104946},{"month":12,"riseRate":0.484848,"avgChangeRate":0.050703}],"exchange":"NASDAQ","name":"Insmed","nameEN":"Insmed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Insmed,INSM,Insmed股票,Insmed股票老虎,Insmed股票老虎国际,Insmed行情,Insmed股票行情,Insmed股价,Insmed股市,Insmed股票价格,Insmed股票交易,Insmed股票购买,Insmed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}